Siemens Healthineers introduces Corindus in India, enabling robotic vascular interventions through best-in-class technology
With Corindus, Siemens Healthineers aims to drive cardiovascular interventions with robotic assistance in India The robot facilitates smart procedural automation, which can enable performing complex interventional cases with shorter time and better clinical outcomes
- With Corindus, Siemens Healthineers aims to drive cardiovascular interventions with robotic assistance in India
- The robot facilitates smart procedural automation, which can enable performing complex interventional cases with shorter time and better clinical outcomes
- Key challenges of limited availability of skilled manpower and clinical infrastructure for minimally invasive procedures in many regions in India can be addressed with this technology
Siemens Healthineers has now added in its portfolio Corindus CorPath GRX, the only FDA cleared and CE certified Robotic System, for Coronary and Peripheral Vascular Interventions in India.
With state-of-art technology, the company has opened a new field for Advanced Therapies business, tapping into adjacent growth markets with great potential for the future.
Robotic systems for minimally invasive procedures help doctors to precisely control guide catheters, guide wires, balloon or stent implants via integrated imaging. The physician does not have to stand at the angiography table as usual but can control the procedure with a separate controlling module and is therefore protected from radiation. Recent studies have shown that the CorPath GRX robot system facilitates upto 20% reduction in radiation dose to patients .
Cardiovascular diseases (CVDs), especially coronary heart disease (CHD), have assumed
epidemic proportions worldwide. India is fast becoming the world’s capital of coronary heart
disease and diabetes, a leading cause of mortality in India. One in 4 deaths in India are because
of CVDs with ischemic heart disease and stroke responsible for more than 80% of this burden,
due to increasing prevalence of CVD risk factors including lifestyle changes2
The robotic cardiovascular interventions can aid significantly in this case, by contributing to cardiovascular medical conditions like heart diseases, where the ideal treatment include complex procedures in the coronary arteries by specialized medical professionals. The smart
procedural automation can enable performing complex interventional cases in shorter time, with precision, and with better clinical outcomes. Adoption of robotics in surgical intervention will provide an enormous impetus to the Indian healthcare sector. Possbilities of remote treatment in the near future (currently under approval) could address the key geographical challenges of limited availability of specialists and corresponding clinical facilities for minimally invasive procedures in many regions. With Corindus technology, Siemens Healthineers is well-positioned to be the leading player in the field of robotic vascular interventions.“Together with our strong portfolio in medical imaging, digitalization and artificial intelligence, we are creating significant synergies to advance therapy outcomes. The
interplay of protection, precision and standardization through robotic-assisted interventions will allow the cardiologists to perform complex procedures faster and better. This will allow specialists to improve procedural quality and expand precision medicine; thereby improving clinical outcomes for the patient.”, said Sanjay David, Head of Advanced Therapies, Siemens Healthineers, India.